A Yawn and More Growth From Wyeth (The Motley Fool via Yahoo! News)
Thursday morning, pharmaceutical company Wyeth (NYSE: WYE - News) released its third-quarter earnings, and the lack of change in its shares was totally expected. It's a case of deja vu seeing these earnings because Wyeth gave forward guidance for the year earlier this month.

Med Enclosure, LLC With Several IRB Approvals With "Non Significant Risk" Determination Withdraws Irrelevant IDE (Medical News Today)
CPC of America, Inc. (OTC Bulletin Board: CPCF.OB) reports that its subsidiary, Med Enclosure, LLC, has withdrawn the Investigational Device Exemption ("IDE") application submitted July 12, 2005 to the U. S. Food and Drug Administration ("FDA"), Center for Devices and Radiological Health under provisions of the Federal Food, Drug, and Cosmetic Act ("Act"), 21 U.S.C. 360j(g), and 21 C.F. [click

FDA Approves Merck Diabetes Drug (RedNova)
PHILADELPHIA _ Federal regulators approved a new diabetes drug Tuesday with two kinds of beneficiaries: millions of people struggling to control their disease, and the drug giant Merck & Co. Inc. laboring to revive its fortunes.